CN108175095A - 一种抑制癌细胞增生的功能食品 - Google Patents
一种抑制癌细胞增生的功能食品 Download PDFInfo
- Publication number
- CN108175095A CN108175095A CN201810127038.3A CN201810127038A CN108175095A CN 108175095 A CN108175095 A CN 108175095A CN 201810127038 A CN201810127038 A CN 201810127038A CN 108175095 A CN108175095 A CN 108175095A
- Authority
- CN
- China
- Prior art keywords
- parts
- nest
- bird
- functional food
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013376 functional food Nutrition 0.000 title claims abstract description 37
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 29
- 201000011510 cancer Diseases 0.000 title claims abstract description 29
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 17
- 206010020718 hyperplasia Diseases 0.000 title claims abstract description 15
- 244000000626 Daucus carota Species 0.000 claims abstract description 75
- 235000005770 birds nest Nutrition 0.000 claims abstract description 75
- 235000005765 wild carrot Nutrition 0.000 claims abstract description 75
- 102000008186 Collagen Human genes 0.000 claims abstract description 30
- 108010035532 Collagen Proteins 0.000 claims abstract description 30
- 229920001436 collagen Polymers 0.000 claims abstract description 30
- 239000009636 Huang Qi Substances 0.000 claims abstract description 28
- 238000000605 extraction Methods 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 241000167854 Bourreria succulenta Species 0.000 claims abstract description 18
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 18
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 18
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 18
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940093265 berberine Drugs 0.000 claims abstract description 18
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000021014 blueberries Nutrition 0.000 claims abstract description 18
- 235000019693 cherries Nutrition 0.000 claims abstract description 18
- 235000013312 flour Nutrition 0.000 claims abstract description 18
- 235000008390 olive oil Nutrition 0.000 claims abstract description 18
- 239000004006 olive oil Substances 0.000 claims abstract description 18
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 17
- 235000012907 honey Nutrition 0.000 claims abstract description 13
- 235000002723 Dioscorea alata Nutrition 0.000 claims abstract description 4
- 235000007056 Dioscorea composita Nutrition 0.000 claims abstract description 4
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 claims abstract description 4
- 235000005362 Dioscorea floribunda Nutrition 0.000 claims abstract description 4
- 235000004868 Dioscorea macrostachya Nutrition 0.000 claims abstract description 4
- 235000005361 Dioscorea nummularia Nutrition 0.000 claims abstract description 4
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 claims abstract description 4
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 claims abstract description 4
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 60
- 239000000284 extract Substances 0.000 claims description 33
- 238000002360 preparation method Methods 0.000 claims description 22
- 239000000706 filtrate Substances 0.000 claims description 20
- 241000219991 Lythraceae Species 0.000 claims description 17
- 239000000047 product Substances 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 230000007062 hydrolysis Effects 0.000 claims description 11
- 238000006460 hydrolysis reaction Methods 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 239000000469 ethanolic extract Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 238000010792 warming Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 8
- 235000019441 ethanol Nutrition 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 230000005764 inhibitory process Effects 0.000 abstract description 7
- 244000294611 Punica granatum Species 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 32
- 239000000243 solution Substances 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 230000001093 anti-cancer Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- QGZCUOLOTMJILH-UHFFFAOYSA-N 2h-tetrazol-2-ium;bromide Chemical compound [Br-].C1=N[NH+]=NN1 QGZCUOLOTMJILH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 208000024207 chronic leukemia Diseases 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010000830 Acute leukaemia Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000021471 food effect Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Alternative & Traditional Medicine (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Husbandry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种抑制癌细胞增生的功能食品,其特征在于,包含如下原料:燕窝萃取胶原蛋白、蜂蜜、樱桃、蓝莓、石榴、橄榄油、山药粉、黄芪、黄连素。本发明功能食品具有良好的抑制癌细胞增生的功效。
Description
技术领域
本发明涉及保健食品领域,尤其涉及一种抑制癌细胞增生的功能食品。
背景技术
众所周知目前流行上市的食品有各种各样。人类的饮食由温饱型向营养型转化,越来越多的人已经自觉地将吃什么与身体的生长、健康长寿、抗衰老、防癌治癌、增智明目等紧密地联系起来。发展功能食品已是当今食品研究开发的新潮流。什么是功能食品,具体的说它是在医学或营养上有特殊要求,并有调节特定生理功能的食品,也就是说它是介乎于一般食品和药品之间。
癌症是严重威胁人类生命健康的恶性疾病,每年会带走大量人的生命,给家庭、社会、国家造成了沉重的负担。由于癌症早期常无特殊症状,甚至毫无症状。目前常规的诊断方法诊断结果基本都为癌症中晚期,错过了最佳的治疗时机,因此癌症的死亡率非常高。长期以来,放化疗是癌症治疗的主要手段之一,然而,放疗和化疗在杀伤肿瘤细胞的同时,也将正常细胞和免疫细胞一同杀灭,导致患者免疫功能受损,免疫力低下,给患者的身体造成了极大的损害。
中医认为药食同源。合理健康的膳食不仅对正常人体健康有重要的意义,而且在恶性肿瘤病人治疗中也起着中药的辅助作用。近代医家张锡纯《医学衷中参西录》中所说,食物“病人服之,不但治病,并可充饥;不但充饥,更可适口,用之对症,病自渐愈,即不对症,亦无他患”。
目前现有技术中的抗癌功能性食品效果不够显著,提供一种抗癌功能显著的功能食品,亟待解决。
发明内容
为解决现有技术中功能食品的防癌抗癌效果不够显著的技术问题,本发明提供一种抗癌效果显著的功能食品,达到不仅能均衡营养,还能起到防癌抗癌的技术效果。
为了实现上述目的,通过如下技术方案予以实现:
一种具有抑制癌细胞增生的功能食品,包含如下原料:燕窝萃取胶原蛋白、蜂蜜、樱桃、蓝莓、石榴、橄榄油、山药粉、黄芪、黄连素。
优选的,所述功能食品包含如下重量份原料:燕窝萃取胶原蛋白20~50份、蜂蜜5~20份、樱桃2~25份、蓝莓3~15份、石榴10~20份、橄榄油1~20份、山药粉5~15份、黄芪1~30份、黄连素5~20份。
优选的,所述功能食品包含如下重量份原料:燕窝萃取胶原蛋白20~30份、蜂蜜5~10份、樱桃2~10份、蓝莓3~10份、石榴10~15份、橄榄油1~15份、山药粉5~10份、黄芪1~20份、黄连素10~15份。
优选的,所述功能食品包含如下重量份原料:燕窝萃取胶原蛋白25份、蜂蜜8份、樱桃8份、蓝莓8份、石榴13份、橄榄油10份、山药粉8份、黄芪15份、黄连素12份。
优选的,所述燕窝萃取胶原蛋白的制备包含如下制备步骤:
(1)将新鲜燕窝洗净,与体积比为60~80%的乙醇按重量比1:60~1:70混合,浸泡至燕窝吸水完全;
(2)将浸泡液升温至30~60℃,保持温度4~6h;
(3)将步骤(2)过滤,得到滤液和滤渣,滤液用40~60℃减压浓缩,得到燕窝乙醇提取物;
(4)步骤(3)滤渣则加入新鲜燕窝重量的50~60倍水,加热至60~90℃,保持温度4~6h,过滤,得到滤液和滤渣,滤液减压浓缩,得到燕窝水提物;
(5)将水提物滤渣,加入新鲜燕窝重量10~15倍量水,用重量百分比为0.1~5%的氢氧化钠水溶液调PH至8~9,升温至40~60℃,降至室温,用盐酸溶液调PH至中性,减压浓缩,得到燕窝碱水解产物。
(6)将上述燕窝乙醇提取物、燕窝水提物、燕窝碱水解产物合并,冻干,得到的粉末为燕窝萃取胶原蛋白。
如上所述功能食品的制备方法,其特征在于,包含如下制备步骤:
(1)按重量份称取原料;
(2)将称取好的新鲜樱桃、蓝莓、石榴加水打成果浆;
(3)黄芪加8~12倍水,水提取4~6h,过滤,得到黄芪水提物;
(4)将果浆、黄芪水提物、燕窝萃取胶原蛋白、橄榄油、山药粉、黄连素混匀,浓缩干燥成膏或粉。
优选的,所述步骤(4)中浓缩干燥后原料的干燥率为70~80%。
优选的,所述步骤(3)中水提温度为60~100℃。
有益效果:
本发明抑制癌细胞增生的功能食品,主要成分为经过提取的燕窝,该燕窝萃取胶原蛋白采用全新的制备工艺,将燕窝进行醇提、水提以及碱水解,全程采用较低温度进行处理,不仅将燕窝有效成分提取完全,还不破坏有效成分的活性,使得采用该燕窝萃取胶原蛋白制作的功能食品,具有良好的抑制癌细胞增生的功效。黄芪和黄连素具有抑制病毒的功效,蜂蜜、樱桃、蓝莓、石榴、橄榄油、山药粉不仅能给人提供多种维生素和矿物质,还具有提高免疫力等功效,这些成分与燕窝萃取胶原蛋白一起使用,具有协同作用,提高抑制癌细胞增生的功效。
具体实施例
实施例1 一种具有抑制癌细胞增生的功能食品
一种具有抑制癌细胞增生的功能食品,包含如下重量份原料:燕窝萃取胶原蛋白20份、蜂蜜5份、樱桃2份、蓝莓3份、石榴10份、橄榄油1~20份、山药粉5份、黄芪1份、黄连素5份。
所述燕窝萃取胶原蛋白的制备包含如下制备步骤:
(1)将新鲜燕窝洗净,与体积比为60%的乙醇按重量比1:60混合,浸泡至燕窝吸水完全;
(2)将浸泡液升温至30℃,保持温度4~6h;
(3)将步骤(2)过滤,得到滤液和滤渣,滤液用40℃减压浓缩,得到燕窝乙醇提取物;
(4)步骤(3)滤渣则加入新鲜燕窝重量的50倍水,加热至60℃,保持温度4h,过滤,得到滤液和滤渣,滤液减压浓缩,得到燕窝水提物;
(5)将水提物滤渣,加入新鲜燕窝重量10倍量水,用重量百分比为0.1%的氢氧化钠水溶液调PH至8,升温至40℃,降至室温,用盐酸溶液调PH至中性,减压浓缩,得到燕窝碱水解产物。
(6)将上述燕窝乙醇提取物、燕窝水提物、燕窝碱水解产物合并,冻干,得到的粉末为燕窝萃取胶原蛋白。
如上所述功能食品的制备方法,其特征在于,包含如下制备步骤:
(1)按重量份称取原料;
(2)将称取好的新鲜樱桃、蓝莓、石榴加水打成果浆;
(3)黄芪加8倍水,60℃水提取4h,过滤,得到黄芪水提物;
(4)将果浆、黄芪水提物、燕窝萃取胶原蛋白、橄榄油、山药粉、黄连素混匀,浓缩干燥成膏,干燥率为70%。
实施例2一种具有抑制癌细胞增生的功能食品
一种具有抑制癌细胞增生的功能食品,包含如下重量份原料:
燕窝萃取胶原蛋白25份、蜂蜜8份、樱桃8份、蓝莓8份、石榴13份、橄榄油10份、山药粉8份、黄芪15份、黄连素12份。
所述燕窝萃取胶原蛋白的制备包含如下制备步骤:
(1)将新鲜燕窝洗净,与体积比为70%的乙醇按重量比1:65混合,浸泡至燕窝吸水完全;
(2)将浸泡液升温至50℃,保持温度5h;
(3)将步骤(2)过滤,得到滤液和滤渣,滤液用50℃减压浓缩,得到燕窝乙醇提取物;
(4)步骤(3)滤渣则加入新鲜燕窝重量的55倍水,加热至80℃,保持温度5h,过滤,得到滤液和滤渣,滤液减压浓缩,得到燕窝水提物;
(5)将水提物滤渣,加入新鲜燕窝重量12倍量水,用重量百分比为2%的氢氧化钠水溶液调PH至8.5,升温至50℃,降至室温,用盐酸溶液调PH至中性,减压浓缩,得到燕窝碱水解产物;
(6)将上述燕窝乙醇提取物、燕窝水提物、燕窝碱水解产物合并,冻干,得到的粉末为燕窝萃取胶原蛋白。
如上所述功能食品的制备方法,其特征在于,包含如下制备步骤:
(1)按重量份称取原料;
(2)将称取好的新鲜樱桃、蓝莓、石榴加水打成果浆;
(3)黄芪加10倍水,90℃水提取5h,过滤,得到黄芪水提物;
(4)将果浆、黄芪水提物、燕窝萃取胶原蛋白、橄榄油、山药粉、黄连素混匀,浓缩干燥成粉,干燥率为80%。
实施例3 一种具有抑制癌细胞增生的功能食品
一种具有抑制癌细胞增生的功能食品,所述功能食品包含如下重量份原料:燕窝萃取胶原蛋白50份、蜂蜜20份、樱桃25份、蓝莓15份、石榴20份、橄榄油20份、山药粉15份、黄芪30份、黄连素20份。
所述燕窝萃取胶原蛋白的制备包含如下制备步骤:
(1)将新鲜燕窝洗净,与体积比为80%的乙醇按重量比1:70混合,浸泡至燕窝吸水完全;
(2)将浸泡液升温至60℃,保持温度6h;
(3)将步骤(2)过滤,得到滤液和滤渣,滤液用60℃减压浓缩,得到燕窝乙醇提取物;
(4)步骤(3)滤渣则加入新鲜燕窝重量的60倍水,加热至90℃,保持温度6h,过滤,得到滤液和滤渣,滤液减压浓缩,得到燕窝水提物;
(5)将水提物滤渣,加入新鲜燕窝重量15倍量水,用重量百分比为5%的氢氧化钠水溶液调PH至9,升温至60℃,降至室温,用盐酸溶液调PH至中性,减压浓缩,得到燕窝碱水解产物。
(6)将上述燕窝乙醇提取物、燕窝水提物、燕窝碱水解产物合并,冻干,得到的粉末为燕窝萃取胶原蛋白。
如上所述功能食品的制备方法,其特征在于,包含如下制备步骤:
(1)按重量份称取原料;
(2)将称取好的新鲜樱桃、蓝莓、石榴加水打成果浆;
(3)黄芪加12倍水,100℃水提取6h,过滤,得到黄芪水提物;
(4)将果浆、黄芪水提物、燕窝萃取胶原蛋白、橄榄油、山药粉、黄连素混匀,浓缩干燥成稿,干燥率75%。
实验检测:
将实施例1、2、3成品,每个实施例成品调制出以下6种浓度:10μg/ml、 20μg/ml、40μg/ml、80μg/ml、160μg/ml、320μg/ml,对照组为市售抗癌功能食品,配置成相同的浓度。然后将其分别加入不同细胞株的各组中,来观察对培养细胞的影响。
细胞株的来源
人体急性白血病细胞(HL-60)(CCL-240,ATCC)
人体慢性白血病细胞(K562) (CCL-243, ATCC)
实体瘤(S 180) (TIB-66,ATCC)
人体乳腺癌细胞(MCF-7) (HTB-22, ATCC)
人体肝癌细胞(HepG2) (HB-8065, ATCC)
正常猴肾细胞(VERO) (CCL-81,ATCC)
培养液
主要有两种培养液:RPMI-1640 (Sigma,R-6540)和DMEM (GIBCO,12100-046)。在使用之前加入10%胎牛血清(GIBCO, 26140-079), 1%青霉素一链霉素(GIBCO, P0781)及0.1%两性霉素B (GIBCO,15290-018)。
培养条件与检测方法
各组细胞(HL-60, K562,S180)培养72小时后,加入等量的0.4%台盼蓝(Trypan blue)进行染色,在显微镜下计数活细胞,从而计算出细胞生长抑制率。
在细胞(MCF-7,HepG2,VERO)培养72h后,以噻唑蓝(MTT)比色法作为测定方法。MTT被加进细胞后会放置在保温箱5小时,然后倒去所有培养液(包括MTT),再加入异丙醇作为溶液,待其完全溶解后在酶联反应仪上测量于570 nm波长的吸光度值,从而计算出细胞生长抑制率。
表1:实施例1产品对癌细胞抑制率(%)
*P值小于0.05,与对照组比较有明显差异;- 表示检测不到活性
表2:实施例 2产品对癌细胞抑制率(%)
*P值小于0.05,与对照组比较有明显差异;- 表示检测不到活性
表3:实施例 3产品对癌细胞抑制率(%)
*P值小于0.05,与对照组比较有明显差异;- 表示检测不到活性
由以上实验数据表明,本发明产品对癌细胞具有非常好的抑制作用,相对于市售产品,具有显著性差异,其中,本发明实施例2的产品,具有最佳的抑制癌细胞增殖的效果,对人体慢性白血病细胞(K562)的抑制率,在浓度为320μg/ml时,抑制率可以达到99%。
Claims (8)
1.一种抑制癌细胞增生的功能食品,其特征在于,包含如下原料:燕窝萃取胶原蛋白、蜂蜜、樱桃、蓝莓、石榴、橄榄油、山药粉、黄芪、黄连素。
2.根据权利要求1所述功能食品,其特征在于,所述功能食品包含如下重量份原料:燕窝萃取胶原蛋白20~50份、蜂蜜5~20份、樱桃2~25份、蓝莓3~15份、石榴10~20份、橄榄油1~20份、山药粉5~15份、黄芪1~30份、黄连素5~20份。
3.根据权利要求2所述功能食品,其特征在于,所述功能食品包含如下重量份原料:燕窝萃取胶原蛋白20~30份、蜂蜜5~10份、樱桃2~10份、蓝莓3~10份、石榴10~15份、橄榄油1~15份、山药粉5~10份、黄芪1~20份、黄连素10~15份。
4.根据权利要求3所述功能食品,其特征在于,所述功能食品包含如下重量份原料:燕窝萃取胶原蛋白25份、蜂蜜8份、樱桃8份、蓝莓8份、石榴13份、橄榄油10份、山药粉8份、黄芪15份、黄连素12份。
5.根据权利要求1~4任一所述所述功能食品,其特征在于,所述燕窝萃取胶原蛋白的制备包含如下制备步骤:
(1)将新鲜燕窝洗净,与体积比为60~80%的乙醇按重量比1:60~1:70混合,浸泡至燕窝吸水完全;
(2)将浸泡液升温至30~60℃,保持温度4~6h;
(3)将步骤(2)过滤,得到滤液和滤渣,滤液用40~60℃减压浓缩,得到乙醇提取物;
(4)滤渣则加入新鲜燕窝重量的50~60倍水,加热至60~90℃,保持温度4~6h,过滤,得到滤液和滤渣,滤液减压浓缩,得到燕窝水提物;
(5)将水提物滤渣,加入新鲜燕窝重量10~15倍量水,用重量百分比为0.1~5%的氢氧化钠水溶液调PH至8~9,升温至40~60℃,降至室温,用盐酸溶液调PH至中性,减压浓缩,得到燕窝碱水解产物;
(6)将上述燕窝乙醇提取物、燕窝水提物、燕窝碱水解产物合并,冻干,得到的粉末为燕窝萃取胶原蛋白。
6.权利要求1~4任一所述功能食品的制备方法,其特征在于,包含如下制备步骤:
(1)按重量份称取原料;
(2)将称取好的新鲜樱桃、蓝莓、石榴加水打成果浆;
(3)黄芪加8~12倍水,水提取4~6h,过滤,得到黄芪水提物;
(4)将果浆、黄芪水提物、燕窝萃取胶原蛋白、橄榄油、山药粉、黄连素混匀,浓缩干燥成膏或粉。
7.根据权利要求6所述功能食品的制备方法,其特征在于,所述步骤(4)中浓缩干燥后原料的干燥率为70~80%。
8.根据权利要求6所述功能食品的制备方法,其特征在于,所述步骤(3)中水提温度为60~100℃。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810127038.3A CN108175095A (zh) | 2018-02-08 | 2018-02-08 | 一种抑制癌细胞增生的功能食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810127038.3A CN108175095A (zh) | 2018-02-08 | 2018-02-08 | 一种抑制癌细胞增生的功能食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108175095A true CN108175095A (zh) | 2018-06-19 |
Family
ID=62552369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810127038.3A Pending CN108175095A (zh) | 2018-02-08 | 2018-02-08 | 一种抑制癌细胞增生的功能食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108175095A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116686976A (zh) * | 2023-06-14 | 2023-09-05 | 厦门燕安居多助食品有限公司 | 一种从燕窝挑毛副产品提取燕窝并制成燕窝冻干粉的工艺 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1951403A (zh) * | 2005-10-21 | 2007-04-25 | 香港中文大学 | 具有抗癌与免疫增强活性的虎乳灵芝提取物及其制备方法 |
CN101313952A (zh) * | 2007-05-31 | 2008-12-03 | 曾广财 | 一种治疗癌症的中草药 |
CN101343653A (zh) * | 2008-08-22 | 2009-01-14 | 中国海洋大学 | 海参胶原蛋白活性肽的制备方法和应用 |
CN102102119A (zh) * | 2010-12-03 | 2011-06-22 | 北京中生奥普寡肽技术研究所 | 燕窝寡肽组合物及其制备方法和使用 |
CN102406114A (zh) * | 2011-10-24 | 2012-04-11 | 保龄宝生物股份有限公司 | 一种膳食纤维燕窝饮品的生产工艺 |
CN103190656A (zh) * | 2013-04-17 | 2013-07-10 | 桂林理工大学 | 一种从浒苔中获得有效物质的方法 |
CN103468761A (zh) * | 2013-09-25 | 2013-12-25 | 重庆工商大学 | 利用菜籽饼粕制备l-阿拉伯糖的方法 |
CN104161798A (zh) * | 2013-05-17 | 2014-11-26 | 天津天士力现代中药资源有限公司 | 一种复方丹参提取物及其应用 |
CN106265746A (zh) * | 2015-05-19 | 2017-01-04 | 广生堂国际有限公司 | 燕窝萃取组成物及含有所述燕窝萃取组成物的食品 |
CN107411069A (zh) * | 2017-07-27 | 2017-12-01 | 杭州玖拾伍度鲜生物科技有限公司 | 一种低温加工的燕窝制品及其制备工艺 |
-
2018
- 2018-02-08 CN CN201810127038.3A patent/CN108175095A/zh active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1951403A (zh) * | 2005-10-21 | 2007-04-25 | 香港中文大学 | 具有抗癌与免疫增强活性的虎乳灵芝提取物及其制备方法 |
CN101313952A (zh) * | 2007-05-31 | 2008-12-03 | 曾广财 | 一种治疗癌症的中草药 |
CN101343653A (zh) * | 2008-08-22 | 2009-01-14 | 中国海洋大学 | 海参胶原蛋白活性肽的制备方法和应用 |
CN102102119A (zh) * | 2010-12-03 | 2011-06-22 | 北京中生奥普寡肽技术研究所 | 燕窝寡肽组合物及其制备方法和使用 |
CN102406114A (zh) * | 2011-10-24 | 2012-04-11 | 保龄宝生物股份有限公司 | 一种膳食纤维燕窝饮品的生产工艺 |
CN103190656A (zh) * | 2013-04-17 | 2013-07-10 | 桂林理工大学 | 一种从浒苔中获得有效物质的方法 |
CN104161798A (zh) * | 2013-05-17 | 2014-11-26 | 天津天士力现代中药资源有限公司 | 一种复方丹参提取物及其应用 |
CN103468761A (zh) * | 2013-09-25 | 2013-12-25 | 重庆工商大学 | 利用菜籽饼粕制备l-阿拉伯糖的方法 |
CN106265746A (zh) * | 2015-05-19 | 2017-01-04 | 广生堂国际有限公司 | 燕窝萃取组成物及含有所述燕窝萃取组成物的食品 |
CN107411069A (zh) * | 2017-07-27 | 2017-12-01 | 杭州玖拾伍度鲜生物科技有限公司 | 一种低温加工的燕窝制品及其制备工艺 |
Non-Patent Citations (5)
Title |
---|
不详: "癌细胞杀手——燕窝", 《搜狐网》 * |
崔慧娥等: "燕窝糖蛋白纯化及多克隆抗体的制备 ", 《食品工业科技》 * |
杜建: "中药抗肿瘤机制研究进展", 《福建中医学院学报》 * |
胡国昌,陈文锐,陈捷,郭长城,欧阳政,吴应亮,熊冠兰,廖俊仪,伍钟斌: "燕窝及其制品的检测方法 ", 《食品科学》 * |
贾公孚等主编: "《临床药物新用联用大全》", 31 August 1999, 人民卫生出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116686976A (zh) * | 2023-06-14 | 2023-09-05 | 厦门燕安居多助食品有限公司 | 一种从燕窝挑毛副产品提取燕窝并制成燕窝冻干粉的工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103355556B (zh) | 一种玉米型断奶仔猪配合饲料及其制备方法 | |
KR101339706B1 (ko) | 홍삼 포접화합물, 면역 농축물 및 유산균을 유효성분으로 함유하는 면역증강 복합 조성물 | |
CN107432473A (zh) | 一种用于预防老年痴呆的功能食品 | |
CN108164615A (zh) | 一种黄精多糖的制备方法及应用 | |
CN103719609A (zh) | 一种哺乳期母猪饲料及其制备方法 | |
CN104905237A (zh) | 桦褐孔菌复合冲剂及其生产方法 | |
CN101554362A (zh) | 一种天然产物的组方及制剂 | |
CN104256166A (zh) | 一种用于治疗牛蓝舌病的功能性饲料及其制备方法 | |
KR20120120515A (ko) | 프로폴리스와 식물 혼합 추출물을 함유하는 항균, 항산화 및 면역 증강 기능이 우수한 건강식품 조성물 및 그 제조방법 | |
CN108175095A (zh) | 一种抑制癌细胞增生的功能食品 | |
CN105028995A (zh) | 一种配合狗粮及其制备方法 | |
US10595547B2 (en) | Solid drink for regulating qi-depression constitution and processing method thereof | |
KR20210027722A (ko) | 약용 및 식용 천연물 복합 발효액을 유효성분으로 함유하는 항균 조성물 | |
CN102652561A (zh) | 治疗微病症或辅助药物康复病体的植物蛋白食品及生产方法 | |
CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
CN105029624A (zh) | 一种黑果枸杞饮料及其制备方法 | |
CN109329897A (zh) | 一种用于癌症的辅助治疗食品组合物及其制备方法 | |
CN110101813A (zh) | 一种治疗肾阳虚牡蛎组合物口服液制备方法及其应用 | |
KR20020057695A (ko) | 야채 종합 비타민 강정제 제조방법 | |
CN104435259B (zh) | 一种中药组合物在制备治疗细菌性乳腺炎药物中的用途 | |
CN108260818A (zh) | 一种具有降血脂、降血糖、降血压、提高免疫力功能的保健食品及其制备方法 | |
CN107929372A (zh) | 治疗甲癣的中药组合物及其制备方法和用途 | |
CN107320548A (zh) | 清咽润肺、清热解毒以及补脾祛燥的养生茶及其制备方法 | |
CN107519429B (zh) | 具有改善脾胃和促进通便排毒功能的中药组合物及制法 | |
CN106387214A (zh) | 一种百香果复合果茶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181214 Address after: 510000 Nancun Town, Panyu District, Guangzhou City, Guangdong Province Applicant after: Guangzhou Weizi Trade Co., Ltd. Address before: 518000 Unit 05, 19th Floor, Building A, Sunshine Kechuang Center, Intersection of Dongbin Road and Nanshan Avenue, Nanshan Street, Nanshan District, Shenzhen City, Guangdong Province Applicant before: Shenzhen only posture Trade Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180619 |
|
RJ01 | Rejection of invention patent application after publication |